Altox

Pharmaceutical impurities

31,702 catalogue designations with a molecular structure. Page 71 of 127.

NameCASFormula
Ganciclovir EP Impurity J177216-32-9C18H25N5O7
Ganciclovir Imp. F (EP): 2-Amino-1,9-dihydro-6H-purin- 6-one (Guanine)73-40-5C5H5N5O
Ganciclovir Imp. H (EP): 2-Amino-7-[[2-hydroxy-1-(hydroxy- methyl)ethoxy]methyl]-1,7-dihydro-6H-purin-6- one (N-7 Isomer of Ganciclovir)84222-50-4C9H13N5O4
Ganciclovir Imp. I (EP): 2-[(2-Amino-6-oxo-1,6-dihydro- 9H-purin-9-yl)methoxy]-propane-1,3-diyl Dipropanoate (Ganciclovir Dipropionate)86357-20-2C15H21N5O6
Ganciclovir Imp. J (EP): 2-[2-(Propanoylamino)-6-oxo-1,6- dihydro-9H-purin-9-yl]methoxy]propane-1,3- diyl dipropanoate (Ganciclovir Tripropionate)177216-32-9C18H25N5O7
Ganciclovir Impurity 11401562-16-0C15H25ClN6O5
Ganciclovir Impurity 286357-14-4C15H19N5O7
Ganciclovir Impurity 3130914-77-1C35H43N7O10
Ganciclovir Impurity 51202645-50-8C7H9N5O2
Ganciclovir Impurity 1086357-19-9C13H17N5O6
Ganciclovir Impurity 13298197-26-9C13H17N5O6
Ganciclovir Impurity 14130914-71-5C19H31N7O6
Ganciclovir Impurity 161219792-42-3C14H22N6O5
Ganciclovir Impurity 1784245-12-5C11H15N5O5
Ganciclovir Impurity D1346598-14-8C10H15N5O5
Ganciclovir Mono-N-methyl Valinate HydrochlorideNot availableC15H25ClN6O5
Ganciclovir Mono-O-acetate88110-89-8C11H15N5O5
Ganciclovir Mono-O-propionate194159-18-7C12H17N5O5
Ganciclovir Related Compound A86357-09-7C9H13N5O4
Ganciclovir Triacetate86357-14-4C15H19N5O7
Garamine triacetateNot availableC19H39N3O12
Gatifloxacin Impurity 1114213-69-3C20H24FN3O4
Gefapixant1015787-98-0C14H19N5O4S
Gefapixant Impurity 1865304-71-8C14H18N4O2
Gefitinib Difluoro Impurity184475-50-1C22H24F2N4O3
Gefitinib Dihydrochloride184475-56-7C22H26Cl3FN4O3
Gefitinib EP Impurity B1603814-04-5C22H24ClFN4O3
Gefitinib Hydrochloride184475-55-6C22H25Cl2FN4O3
Gefitinib Hydrolysate Precursor (HCl)184475-70-5C17H14Cl2FN3O3
Gefitinib Impurity 352805-46-6C8H7NO2
Gefitinib Impurity 4385784-68-9C12H15N3O2
Gefitinib Impurity 5675126-27-9C15H21N3O3
Gefitinib Impurity 62089650-13-3C22H24Cl2N4O3
Gefitinib Impurity 71608115-59-8C22H23ClFN3O4
Gefitinib Impurity 8214472-37-4C16H22N2O7
Gefitinib Impurity 91640351-46-7C15H22N2O5
Gefitinib Impurity 10690206-97-4C16H13ClFN3O2
Gefitinib Impurity 1116064-25-8C8H6N2O2
Gefitinib Impurity 12385784-71-4C15H19N3O5
Gefitinib Impurity 13215659-03-3C9H9NO6
Gefitinib Impurity 15847949-50-2C22H25ClN4O4
Gefitinib Impurity 191803045-02-4C22H24ClFN4O4
Gefitinib Impurity 24194423-17-1C10H12N4
Gefitinib Impurity 25214472-41-0C16H24N2O5
Gefitinib Impurity 26193552-54-4C18H16O6
Gefitinib Impurity 281379208-77-1C8H6N2O4
Gefitinib impurity 29184475-35-2C22H24ClFN4O3
Gefitinib Impurity 31692059-41-9C12H12Cl2N2O2
Gefitinib Impurity 3272235-56-4C7H7ClFN
Gefitinib impurity 33Not availableC22H24ClFN4O3
Gefitinib Impurity 35861453-12-5C15H20N2O6
Gefitinib Impurity 351325726-60-0C11H11BrN2O4
Gefitinib Impurity 36861453-11-4C15H21NO4
Gefitinib Impurity 3721397-08-0C6H5ClFN
Gefitinib Impurity 382106-04-9C6H5ClFN
Gefitinib Impurity 3958749-47-6C8H7NO5
Gefitinib Impurity 406702-50-7C9H10O4
Gefitinib Impurity 433863-11-4C6H5F2N
Gefitinib Impurity 431072107-50-6C11H12ClNO5
Gefitinib Impurity 44675126-26-8C15H19N3O5
Gefitinib Impurity 45205584-69-6C9H6Cl2N2O
Gefitinib Impurity 471208903-74-5C8H8N2O2
Gefitinib Impurity 48385784-72-5C15H21N3O3
Gefitinib Impurity 70199327-59-8C16H20ClN3O3
Gefitinib Impurity 72179688-02-9C11H10N2O4
Gefitinib Impurity 7380547-65-5C8H7NO6
Gefitinib impurity C847949-51-3C22H24ClFN4O4
Gefitinib impurity F153437-78-6C16H13ClFN3O2
Gefitinib Impurity G50413-44-0C9H11NO4
Gefitinib impurity G847949-49-9C21H22ClFN4O3
Gefitinib impurity H199327-61-2C16H21N3O4
Gefitinib impurity I847949-56-8C20H22ClFN4O3
Gefitinib Impurity K367-21-5C6H5ClFN
Gefitinib impurity K1006378-06-8C15H19N3O5
Gefitinib impurity L246512-44-7C15H23N3O4
Gefitinib impurity O861453-16-9C15H21N3O6
Gefitinib Impurity P1502829-45-9C29H37ClFN5O4
Gefitinib Impurity TE184475-68-1C22H25ClF2N4O3
Gefitinib Intermediate I26759-46-6C10H13NO4
Gefitinib Intermediate II13794-72-4C10H10N2O3
Gefitinib Intermediate III179688-52-9C9H8N2O3
Gefitinib Intermediate IV179688-53-0C11H10N2O4
Gefitinib Intermediate V230955-75-6C11H9ClN2O3
Gefitinib Intermediate VI788136-89-0C17H13ClFN3O3
Gefitinib Intermediate VII184475-71-6C15H11ClFN3O2
Gefitinib Intermediate VIII7357-67-7C7H14ClNO
Gefitinib N-Oxide847949-51-3C22H24ClFN4O4
Gefitinib-13C-D31210608-91-5C22H24ClFN4O3
Gefitinib-D31173976-40-3C22H24ClFN4O3
Gefitinib-D61228664-49-0C22H24ClFN4O3
Gefitinib-D8857091-32-8C22H24ClFN4O3
Gefitinib-PROTAC-32230821-27-7C47H57ClFN7O8S
Gemcitabine EP Impurity B122111-05-1C9H12ClF2N3O4
Gemcitabine hydrochloride EP impurity A/Lamivudine EP impurity E71-30-7C4H5N3O
Gemcitabine Hydrochloride Imp. A (EP): 4-Aminopyrimidin-2(1H)-one (Cytosine)71-30-7C4H5N3O
Gemcitabine Hydrochloride Imp. C EP: 1-(2-Deoxy-2,2-difluoro- -D-erythro-pentofuranosyl) pyrimidin-2,4(1H,3H)-dione (2 -Deoxy-2 ,2 -difluorouridine)114248-23-6C9H10F2N2O5
Gemcitabine Impurity 1122111-01-7C19H14F2O6
Gemcitabine Impurity 2143157-22-6C19H16F2O6
Gemcitabine Impurity 3153381-14-7C9H10F2N2O5
Gemcitabine Impurity 495058-77-8C5H6F2O4
Gemcitabine Impurity 4134877-42-2C20H18F2O8S
Gemcitabine Impurity 5122111-12-0C5H6F2O4
Gemcitabine Impurity 6122111-02-8C19H14F2O6
Gemcitabine Impurity 7134790-39-9C23H19F2N3O6
Gemcitabine Impurity 7122111-07-3C12H10F2O5
Gemcitabine Impurity 8143234-91-7C14H16F2O6
Gemcitabine Impurity 9866473-31-6C19H16F2O7
Gemcitabine Impurity 152174019-90-8C16H15F2N3O5
Gemcitabine impurity A71-30-7C4H5N3O
Gemcitabine impurity C114248-23-6C9H10F2N2O5
Gemcitabine impurity C114248-23-6C9H10F2N2O5
Gemfibrozil EP impurity B114413-97-7C15H23NO2
Gemfibrozil EP impurity CNot availableC15H24O3
Gemfibrozil EP impurity E500904-61-0C18H26O3
Gemfibrozil EP impurity F500904-64-3C18H22O
Gemfibrozil EP impurity G3727-20-6C11H14O
Gemfibrozil EP impurity H415724-02-6C19H24O2
Gemfibrozil EP impurity I149105-25-9C16H24O3
Gemfibrozil Ethyl Ester63258-18-4C17H26O3
Gemfibrozil for system suitability25812-30-0C15H22O3
Gemfibrozil Imp. A (EP): 2,5-Dimethylphenol (p-Xylenol)95-87-4C8H10O
Gemfibrozil Imp. E (EP): 5-[2,5-Dimethyl-4-(prop-1-enyl)- phenoxy]-2,2-dimethylpentanoic Acid1315604-10-4C18H26O3
Gemfibrozil Imp. H (EP): 1,3-Bis(2,5-dimethylphenoxy)- propane415724-02-6C19H24O2
Gemfibrozil Imp. I (EP): Methyl 5-(2,5-dimethylphenoxy)-2,2- dimethylpentanoate (Gemfibrozil Methyl Ester)149105-25-9C16H24O3
Gemfibrozil impurity 163258-18-4C17H26O3
Gemfibrozil impurity 2154021-24-6C18H28O3
Gemfibrozil impurity 391683-38-4C21H30O9
Gemfibrozil impurity E500904-61-0C18H26O3
Gemfibrozil Impurity E500904-61-0C18H26O3
Gemfibrozil Isobutyl EsterNot availableC19H30O3
Gemfibrozil Isobutyl Ester149105-26-0C19H30O3
Gemfibrozil Isopropyl Ester154021-24-6C18H28O3
Gemfibrozil methyl ester149105-25-9C16H24O3
Gemfibrozil Related Compound A500904-61-0C18H26O3
GemigliptinNot availableC18H19F8N5O2
Geniposide methyl ester64421-28-9C17H26O11
Genistein Diglucuronide428438-35-1C27H26O17
Gentamicin B36889-15-3C19H38N4O10
Gentamicin C1a26098-04-4C19H39N5O7
Gentamicin C225876-11-3C20H41N5O7
Gentamicin C2a59751-72-3C20H41N5O7
Gentamicin C2b52093-21-7C20H41N5O7
Gentamicin Sulfate C2287916-51-2C20H41N5O7
Gentamicin sulfate EP Impurity A32385-11-8C19H37N5O7
Gentamicin sulfate EP Impurity B49751-51-1C13H27N3O6
Gentamicin sulfate EP Impurity C36889-16-4C20H40N4O10
Gentamicin sulfate EP Impurity DNot availableC19H39N5O9
Gentamicin Sulfate EP Impurity E2037-48-1C6H14N2O3
Gentamicin Sulfate EP Impurity E DiHBr84107-26-6C6H16Br2N2O3
Gentamicina1405-41-0C60H125N15O25S
Gentamicina1405-41-0C60H125N15O25S
Gentisic Acid490-79-9C7H6O4
GENZ-123346491833-30-8C24H38N2O4
Geranylgeraniol-d5174873-05-3C20H34O
Gestodene EP Impurity LNot availableC21H26O2
Gestodene for system suitability60282-87-3C21H26O2
Gestodene Impurity 1104933-97-3C21H28O4
Gestodene impurity INot availableC22H30O3
Gibberellin A196980-44-5C20H26O6
Gibberellin A4436434-15-8C20H26O5
Gibberellin impurity 313744-18-8C20H26O4
Gibberenone17924-92-4C18H22O5
Gimeracil impurity 1149143-68-0C6H3ClN2O2
Gimeracil impurity 21379260-15-7C6H6ClNO2
Gimeracil impurity 4149143-67-9C6H5ClN2O3
Gimeracil impurity 5147619-40-7C7H5ClN2O2
Gimeraux impurities152545-13-8C6H7NO2
Gimeraux impurities221642-98-8C7H6N2O2
Ginsenoside Rg1 reference substance22427-39-0C42H72O14
Glabridin (racemate )850582-15-9C20H20O4
Glabridin (S configuration)872596-23-1C20H20O4
Glibenclamide EP Impurity B21165-77-5C18H19ClN2O6S
Glibenclamide Imp. A (EP): 5-Chloro-2-methoxy-N-[2- (4-sulfamoylphenyl)ethyl]benzamide16673-34-0C16H17ClN2O4S
Glibenclamide Imp. B (EP): Methyl [[4-[2-[(5-Chloro-2- methoxybenzoyl)amino]ethyl]phenyl]- sulphonyl]carbamate21165-77-5C18H19ClN2O6S
Glibenclamide Imp. C (EP): 1-Cyclohexyl-3-[[4-[2-[(cyclohexylcarbamoyl) amino]ethyl]phenyl]sulfonyl]urea (N-(Cyclohexylcarbamoyl)-4- [2-[(cyclohexylcarbamoyl)amino]ethyl]benzenesulphonamide)10079-35-3C22H34N4O4S
Glibenclamide Imp. D (EP): 1-Butyl-3-[[4-[2-[(5-chloro-2-methoxybenzoyl) amino]ethyl]phenyl]sulfonyl]urea (1-[[4-[2-[(5-Chloro-2- methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]-3-butylurea)38160-73-5C21H26ClN3O5S
Glibenclamide Imp. E (EP): 1-Cyclohexyl-3-[[4-[2-[(3,5-dichloro-2- methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]urea (1-[[4-[2-[(3,5- Dichloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]-3- cyclohexylurea)57334-89-1C26H40N2O5
Glibenclamide impurity 12191-62-0C17H25N3O4S
Glibenclamide impurity 633924-49-1C16H16ClNO2
Glibenclamide impurity 9 (5-Chloro-2-methoxybenzoic acid)3438-16-2C8H7ClO3
Glibenclamide impurity 10151890-69-6C19H21ClN2O6S
Glibenclamide impurity A16673-34-0C16H17ClN2O4S
Glibenclamide impurity B21165-77-5C18H19ClN2O6S
Glibenclamide impurity B21165-77-5C18H19ClN2O6S
Gliclazide EP Impurity B54786-86-6C7H12N2O
Gliclazide EP Impurity C5577-13-9C10H13NO4S
Gliclazide EP Impurity D1136426-19-1C15H20N2O3S
Gliclazide EP Impurity ENot availableC15H19N3O3S
Gliclazide EP Impurity F1076198-18-9C15H21N3O3S
Gliclazide EP Impurity GNot availableC15H19N3O3S
Gliclazide Imp. A (EP): 4-Methylbenzenesulphonamide70-55-3C7H9NO2S
Gliclazide Imp. B (EP): 2-Nitroso-octahydrocyclopenta- [c]pyrrole54786-86-6C7H12N2O
Gliclazide Imp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]- carbamate5577-13-9C10H13NO4S
Gliclazide Imp. F (EP): 1-(Hexahydrocyclopenta[c]pyrrol- 2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea1076198-18-9C15H21N3O3S
Gliclazide Impurity 138173-52-3C15H19N3O5S
Gliclazide Impurity 214437-03-7C9H11NO4S
Gliclazide Impurity 354528-00-6C7H14N2
Gliclazide Impurity 3 HCl58108-05-7C7H15ClN2
Gliclazide Impurity 539051-77-9C8H10N2O3S
Gliclazide Impurity 887368-00-1C15H21N3O4S
Gliclazide Impurity 91808087-53-7C15H19N3O3S
Gliclazide Impurity 1032258-50-7C10H13NO4S
Gliclazide impurity B54786-86-6C7H12N2O
Gliclazide impurity FNot availableC15H21N3O3S
Gliclazide Impurity F1076198-18-9C15H21N3O3S
Gliclazide impurity F1076198-18-9C15H21N3O3S
Glimepiride Carbamate119018-30-3C18H23N3O6S
Glimepiride cis-Isomer (Glimepiride Related Compound A)684286-46-2C24H34N4O5S
Glimepiride EP impurity A684286-46-2C24H34N4O5S
Glimepiride EP impurity B119018-29-0C16H21N3O4S
Glimepiride EP impurity C119018-30-3C18H23N3O6S
Glimepiride EP impurity D791104-62-6C24H34N4O5S
Glimepiride EP impurity FNot availableC18H23N3O6S
Glimepiride EP impurity GNot availableC19H25N3O6S
Glimepiride EP impurity HNot availableC24H28N4O5S
Glimepiride for system suitability93479-97-1C24H34N4O5S
Glimepiride Imp. A (EP): 1-[[4-[2-[[(3-Ethyl-4-methyl-2- oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]- amino]ethyl]phenyl]sulphonyl]-3-(cis-4- methylcyclohexyl)urea (cis-Glimepiride)684286-46-2C24H34N4O5S
Glimepiride Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N-[2-(4- sulphamoylphenyl)ethyl]-2,3-dihydro-1H-pyrrole- 1-carboxamide (Glimepiride Sulphonamide)119018-29-0C16H21N3O4S
Glimepiride Imp. C (EP): Methyl [[4-[2-[[(3-Ethyl-4-methyl-2- oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]- ethyl]phenyl]sulphonyl]carbamate (Glimepiride Carbamate)119018-30-3C18H23N3O6S
Glimepiride Imp. D (EP): 1-[[3-[2-[[(3-Ethyl-4-methyl-2-oxo- 2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]- phenyl]sulphonyl]-3-(trans-4-methylcyclohexyl)- urea791104-62-6C24H34N4O5S
Glimepiride impurity 1119043-16-2C16H19ClN2O4S
Glimepiride impurity 26850-63-1C8H17N
Glimepiride Impurity 732175-00-1C8H13NO
Glimepiride Impurity 12878480-70-7C24H34N4O5S
Glimepiride Impurity 1441176-98-1C16H25N3O3S
Glimepiride Impurity A2366968-77-4C16H21N3O4S
Glimepiride Related Compound A (glimepiride cis-isomer)Not availableC24H34N4O5S
Glimepiride Related Compound B119018-29-0C16H21N3O4S
Glimepiride Related Compound B (glimepiride sulfonamide)Not availableC16H21N3O4S
Glimepiride Related Compound C119018-30-3C18H23N3O6S
Glimepiride Related Compound D791104-62-6C24H34N4O5S
Glimepiride Sulfonamide119018-29-0C16H21N3O4S
Glipizide EP Impurity A (Trelagliptin EP Impurity A)33288-71-0C14H16N4O3S
Glipizide EP Impurity B157973-60-9C6H13N
Glipizide EP Impurity C (Trelagliptin EP Impurity C)13554-93-3C18H27N3O5S
Glipizide EP Impurity D (Trelagliptin EP Impurity D)1346600-54-1C14H16N4O3S
Glipizide EP Impurity E (Trelagliptin EP Impurity E)66375-96-0C21H27N5O4S
Glipizide EP Impurity F (Trelagliptin EP Impurity F)192118-08-4C11H16N2O4S
Glipizide EP Impurity G (Trelagliptin EP Impurity G)33288-74-3C16H18N4O5S
Glipizide EP Impurity H (Trelagliptin EP Impurity H)10080-05-4C15H23N3O3S
Glipizide EP Impurity I (Trelagliptin EP Impurity I)10079-35-3C22H34N4O4S
Glipizide EP Impurity J1076198-09-8C17H20N4O5S
Glipizide Imp. A (EP): 5-Methyl-N-[2-(4-sulphamoyl- phenyl)ethyl]pyrazine-2-carboxamide33288-71-0C14H16N4O3S
Glipizide Imp. B (EP): Cyclohexanamine108-91-8C6H13N
Glipizide Imp. E (EP): 1-Cyclohexyl-3-[[4-[2-[[(6-methyl- pyrazin-2-yl)carbonyl]amino]ethyl]phenyl]- sulphonyl]urea66375-96-0C21H27N5O4S
Glipizide Imp. F (EP): Ethyl [2-(4-Sulphamoylphenyl)- ethyl]carbamate192118-08-4C11H16N2O4S
Glipizide Imp. G (EP): Methyl [[4-[2-[[(5-Methylpyrazin- 2-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]- carbamate33288-74-3C16H18N4O5S
Glipizide Imp. H (EP): 4-[2-[(Cyclohexylcarbamoyl)amino]- ethyl]benzenesulphonamide10080-05-4C15H23N3O3S
Glipizide Imp. I (EP): N-(Cyclohexylcarbamoyl)-4-[2- [(cyclohexylcarbamoyl)amino]ethyl]benzene- sulphonamide10079-35-3C22H34N4O4S
Glipizide Impurity 4 (4-(2-Aminoethyl)benzenesulfonamide)35303-76-5C8H12N2O2S